Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares UltraPro Short QQQ ETF (SQQQ) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

ProShares UltraPro Short QQQ ETFTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

ProShares UltraPro Short QQQ ETF vs Health Care Select Sector SPDR Fund — how do they compare? ProShares UltraPro Short QQQ ETF trades at $40.61, while Health Care Select Sector SPDR Fund trades at $160.11. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.

SQQQXLV
Sector
Leveraged / Inverse
52-Week High
$97.60$164.48
52-Week Low
$36.31$129.01

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares UltraPro Short QQQ ETF

SQQQ trades at $42.68, down 0.26% on the day, with a bullish technical signal from moving averages but neutral oscillators. As a leveraged inverse ETF, it aims to deliver -3x the daily return of the Nasdaq-100, making it a tactical tool for hedging or short-term bearish bets rather than a long-term investment. Recent news highlights its role in protecting QQQ holdings but warns of severe erosion from daily resets.

The outlook for SQQQ is highly speculative, suited only for experienced traders timing tech sector declines. Key risks include volatility decay and reliance on accurate market timing, with long-term performance showing near-total loss since inception. It offers no fundamental value like earnings or dividends, serving purely as a hedging instrument.

Health Care Select Sector SPDR Fund

XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.

XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ProShares UltraPro Short QQQ ETF

SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.

Read more on SQQQ

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV